Dolutegravir monotherapy: still no longer recommended in either research or clinical practice
24 August 2018. Related: Conference reports, Treatment strategies.
World AIDS 14 Barcelona 2002
First randomised kick-and-kill cure study fails to reduce HIV reservoir: RIVER study reports vorinostat and vaccines show activity, but not enough
3 August 2018. Related: Conference reports, Cure-related research.
Initial antiretroviral therapy: further insights on when to start and what to use
13 October 2002. Related: On the web.
Antiretroviral therapy in treatment-experienced patients
13 October 2002. Related: On the web.
Update on lipodystrophy…or is it just lipoatrophy?
13 October 2002. Related: On the web.
FRAM study and lipodystrophy: lipodystrophy study presented at Barcelona and an interview with the study author Carl Grunfeld
13 October 2002. Related: On the web.
XIV International AIDS Conference Barcelona, 7-12 July 2002
11 September 2002. Related: Conference reports.
Bill Clinton and Nelson Mandela promise to lead peer education among political leaders as world looks for $10 billion a year to fight HIV/AIDS
11 September 2002. Related: Conference reports, Treatment access.
South African activist unveils campaign to force compulsory licences
11 September 2002. Related: Conference reports, Treatment access.
MSF study shows treatment in resource-poor settings is effective
11 September 2002. Related: Conference reports, Treatment access.
‘Barcelona Declaration’ demands 2m poor people are treated in the next two years
11 September 2002. Related: Conference reports, Treatment access.
Health should be a right, not a commodity, and medicine must be removed from the World Trade Organisation, argues key speaker
11 September 2002. Related: Conference reports, Treatment access.
Civil society had to fight for universal access to AIDS drugs in Brazil
11 September 2002. Related: Conference reports, Treatment access.
ART can successfully tackle advanced disease in resource poor settings, reports MSF
11 September 2002. Related: Conference reports, Treatment access.
Investment in treatment and care significantly reduces company health and social expenditure in Abidjan
11 September 2002. Related: Conference reports, Treatment access.
Financing the global response to the epidemic will cost $9.2 billion a year, according to one estimate
11 September 2002. Related: Conference reports, Treatment access.
The Global Fund: what, where, how much?
11 September 2002. Related: Conference reports, Treatment access.
14 Caribbean governments sign cut-price drugs agreement with six pharmaceutical companies
11 September 2002. Related: Conference reports, Treatment access.
Thailand offers low-cost transfer to African countries of technology for the local production of generic antiretrovirals
11 September 2002. Related: Conference reports, Treatment access.
Informal market plays a role in distributing antiretrovirals but exposes clients to risks
11 September 2002. Related: Conference reports, Treatment access.
Abacavir hypersensitivity reactions in patients who rechallenge after interruptions for reasons other than hypersensitivity
11 September 2002. Related: Conference reports, Side effects.
Four drug regimen for infants
11 September 2002. Related: Conference reports, Paediatric care.
Study of MTCT programme finds resistance in women on two doses of monotherapy
11 September 2002. Related: Conference reports, Pregnancy, Drug resistance.
Emergence of resistance in children treated with ddI/d4T after treatment to reduce MTCT
11 September 2002. Related: Conference reports, Paediatric care.
Correlates of fatigue in HIV disease
11 September 2002. Related: Conference reports.
Optimum hydroxyurea dose determined
11 September 2002. Related: Conference reports.
Management of people with treatment experience and drug resistance
11 September 2002. Related: Conference reports, Antiretrovirals.
Lopinavir/r exhibits sustained virologic response in antiretroviral-naïve patients: 3-year data
11 September 2002. Related: Conference reports, Antiretrovirals.
Patients will have options regarding T-20 (enfuvirtide) injection sites
11 September 2002. Related: Conference reports, Antiretrovirals.
The role of tenofovir in antiretroviral-naive patients
11 September 2002. Related: Conference reports, Antiretrovirals.
Treatment interruption strategy reports from the XIV International AIDS Conference
11 September 2002. Related: Conference reports, Treatment strategies.
New data from clinical trials of antiretrovirals
11 September 2002. Related: Conference reports, Antiretrovirals.
Behind the headlines about vaccine research
11 September 2002. Related: Conference reports, Vaccines and microbicides.
Adherence research roundup from the International AIDS Conference
11 September 2002. Related: On the web.
Additional AIDS 2002 reports at thebody.com
11 September 2002. Related: On the web.
NATAP reports from AIDS 2002 Barcelona
11 September 2002. Related: On the web.
1,500 community representatives expected at Barcelona community forum
11 June 2002. Related: Other news.
Barcelona conference organisers issue nine-point plan of action on global emergency
11 May 2002. Related: Other news.